Study of Oral Ridaforolimus in Combination With Standard Chemotherapy for Soft Tissue Sarcoma

NCT01296659 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Principal Investigator left institution.

Conditions

Soft Tissue Sarcoma

Interventions

DRUG: ridaforolimus

Sponsor

The University of Texas Health Science Center at San Antonio

Collaborators

[object Object]